UK
UK Launches Ad-Smart Trial to Halve Time Needed to Test Alzheimer’s Treatments
More than 1,200 NHS patients will test metformin and atomoxetine in parallel under a new platform-trial design, backed…
More than 1,200 NHS patients will test metformin and atomoxetine in parallel under a new platform-trial design, backed…